Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395).
D000276:Adjuvants, Immunologic; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D048588:Benzoxazines; D001794:Blood Pressure / Q000187:drug effects; D002351:Carrageenan; D004232:Diuretics / Q000494:pharmacology; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004569:Electroencephalography; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use*; D010080:Oxazoles / Q000494:pharmacology / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced
D000276:Adjuvants, Immunologic; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D048588:Benzoxazines; D004232:Diuretics; D010078:Oxazines; D010080:Oxazoles; C006165:meseclazone; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin